August 2009  << Back  

A case report of high-dose transdermal selegiline in the treatment of major depressive disorder

Adam Keller Ashton, MD

Clinical Professor of Psychiatry, State University of New York at Buffalo, School of Medical Sciences, Suburban Psychiatric Associates, Amherst, NY, USA

KEYWORDS: selegiline transdermal patch, topical, depression, high dose, off-label dosing

ANNALS OF CLINICAL PSYCHIATRY 2009;21(1):51–52

CORRESPONDENCE: Adam Keller Ashton, MD, State University of New York at Buffalo, School of Medical Sciences, Suburban Psychiatric Associates, 85 Bryant Woods South, Amherst, NY 14228. E-MAIL: aashton@suburbanpsych.org
Annals of Clinical Psychiatry ©2009 American Academy of Clinical Psychiatrists

 
Read full article